Mejia OAV, Borgomoni GB, Silveira LMV, Guerreiro GP, Falcão Filho ATG, Goncharov M, Dallan LRP, Oliveira MAP, de Sousa AG, Nakazone MA, Tiveron MG, Campagnucci VP, de Barros E Silva PGM, Dallan LAO, Lisboa LAF, and Jatene FB
Background and Aim of the Study: This study analyzed the arrival of coronavirus disease 2019 (COVID-19) in Brazil and its impact on coronary artery bypass grafting (CABG) surgery., Methods: Patients undergoing isolated CABG in six hospitals in Brazil were divided into two periods: pre-COVID-19 (March-May 2019, N = 468) and COVID-19 era (March-May 2020, N = 182). Perioperative data were included on a dedicated REDCap platform. Patients with clinical and tomographic criteria and/or PCR (+) for severe acute respiratory syndrome coronavirus 2 infection were considered COVID-19 (+). Logistic regression analysis was performed to create a multiple predictive model for mortality after CABG in COVID-19 era., Results: Compared to 2019, in 2020, CABG surgeries had a 2.8-fold increased mortality risk (95% confidence interval [CI]: 1-7.6, p = .041), patients who evolved with COVID-19 had a 11-fold increased mortality risk (95% CI: 2.2-54.9, p < .003), rates of morbidities and readmission to the intensive care unit. The surgical volume was decreased by 60%. The model to predict mortality after CABG in the COVID-19 era was validated with good calibration (Hosmer-Lemeshow = 1.43) and discrimination (receiver operating characteristic = 0.78)., Conclusion: The COVID-19 pandemic had an adverse impact on mortality, morbidity and volume of patients undergoing CABG., (© 2021 Wiley Periodicals LLC.)